NCT02212860 2026-02-11
SIGNAL 2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
Clinical Trials
14 trialsNCT06417190 2026-02-04
Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology
Cedars-Sinai Medical Center
Phase 2 Recruiting
NCT06739655 2026-02-04
PRADAIIBE
Cancer Research Antwerp
Phase NA Recruiting
NCT02420509 2025-06-04
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
University of California, San Diego
Terminated
NCT03406650 2025-05-04
SAKK 06/17
Swiss Cancer Institute
Phase 2 Completed
NCT05496491 2024-10-08
Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial
Larissa University Hospital
Phase NA Recruiting
NCT05912062 2023-09-29
BiOnHER
Institut Català d'Oncologia
Unknown
NCT02277938 2021-03-17
Acetylamantadine Excretion by Cancer Patients
University of Manitoba
Unknown
NCT04031612 2019-07-24
NEOADJ
Centre Georges Francois Leclerc
Unknown
NCT00107003 2018-07-05
GW572016 to Treat Recurrent Malignant Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01458717 2018-05-02
Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer
Seoul National University Hospital
Phase 2/3 Completed
NCT00491816 2017-01-19
Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer
University of Kansas Medical Center
Phase 2 Unknown
NCT01713218 2012-10-24
NEOPACHI-001
Erasme University Hospital
Phase EARLY_PHASE1 Unknown
NCT00232206 2011-05-18
Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer
Providence Health & Services
Phase 2 Terminated